|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 2451 Crystal Drive |
Address2 | Suite 900 |
City | Arlington |
State | VA |
Zip Code | 22202 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 2230-12
|
||||||||
|
6. House ID# 321920000
|
TYPE OF REPORT | 8. Year | 2017 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: LaShawn McIver, Senior Vice President, Government Affairs & Advocacy |
Date | 1/22/2018 8:20:50 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
1 and 2.) Federal Legislation and Issues
(H.R. designates work with House of Representatives; S. designates work with Senate)
S. 1724/H.R. 4260, the Healthy Food Access for All Americans Act. Support entire bill; encourages organizations and businesses to provide access to healthy foods in urban and rural food deserts.
H.R. 309/S.920, the National Clinical Care Commission Act. Support entire bill; creates a commission to integrate federal research, prevention, and clinical efforts on diabetes and related metabolic and autoimmune diseases.
H.R. 2593, the Preventive Health Savings Act. Support entire bill; legislation allows the Congressional Budget Office to analyze legislation beyond the first ten-year budget window to assess savings based on preventive health activities.
H.R. 2077, the Restoring the Patients Voice Act of 2017. Support entire bill requires employer-sponsored health plans that employ step therapy to implement a clear process by which the patient or provider can request an exception and that the exceptions process must be made readily available on the website of the health plan.
H.R. 3922, the CHAMPIONING HEALTHY KIDS Act. Oppose bill. The Association supports 2-year reauthorization of the Special Diabetes Program; opposes the legislations offset to the Prevention and Public Health Fund. The Association supports the Prevention and Public Health Fund established by the ACA and opposes any legislative efforts to weaken and or cut the fund.
H.R. 1, the Tax Cuts and Jobs Act. Opposed the provision in the bill that repealed the individual mandate in the Affordable Care Act (ACA). The Association opposes legislative efforts to weaken the ACA.
The Bipartisan Health Care Act (Alexander-Murray legislation.) Support the bill which would extend the cost-sharing reduction payments and provides other mechanisms to stabilize the insurance market.
Issues worked on not yet reflected in legislation:
Special Diabetes Program. The Association supports reauthorization of the program and is working on permanent or multi-year renewal before the September 2017 expiration date. A portion of the program was temporarily reauthorized through the Federal Aviation Administration reauthorization.
Cost of prescription drugs. The Association is concerned about the rising cost of insulin and other diabetes medications. The Association has not endorsed any legislative proposal but has advocated for Congress to hold hearings with all parties in the insulin supply chain to increase transparency and ultimately make insulin more affordable for patients.
Diabetes Self-Management Training (DSMT) Legislation. The Association supports efforts to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. HCR
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office, Centers For Disease Control & Prevention (CDC), Natl Institutes of Health (NIH), Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Meghan |
Riley |
|
|
|
Robert |
Goldsmith |
|
|
|
Gwendolyn |
Rathburn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
1 and 2.) Federal Legislation and Issues
(H.R. designates work with House of Representatives; S. designates work with Senate)
S 1519, National Defense Authorization Act for FY 2018. Oppose provisions that would limit the Congressionally Directed Medical Research Program
H.R. 601/H.R. 3358/H.R. 3554/S.1771FY 2018 House/Senate Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. Association is interested in funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies.
Issues worked on not yet reflected in legislation:
Senate Department of Defense Appropriations Act for FY2018. Support inclusion of diabetes as a disease eligible for the Congressionally Directed Medical Research Program.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Disease Control & Prevention (CDC), Natl Institutes of Health (NIH)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Meghan |
Riley |
|
|
|
Gwendolyn |
Rathburn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |